188 related articles for article (PubMed ID: 10609920)
1. Intradermal anti-loxosceles Fab fragments attenuate dermonecrotic arachnidism.
Gomez HF; Miller MJ; Trachy JW; Marks RM; Warren JS
Acad Emerg Med; 1999 Dec; 6(12):1195-202. PubMed ID: 10609920
[TBL] [Abstract][Full Text] [Related]
2. Direct correlation between diffusion of Loxosceles reclusa venom and extent of dermal inflammation.
Gomez HF; Greenfield DM; Miller MJ; Warren JS
Acad Emerg Med; 2001 Apr; 8(4):309-14. PubMed ID: 11282664
[TBL] [Abstract][Full Text] [Related]
3. Management of the brown recluse spider bite.
Rees R; Shack RB; Withers E; Madden J; Franklin J; Lynch JB
Plast Reconstr Surg; 1981 Nov; 68(5):768-73. PubMed ID: 7291346
[TBL] [Abstract][Full Text] [Related]
4. Analysis of therapeutic benefits of antivenin at different time intervals after experimental envenomation in rabbits by venom of the brown spider (Loxosceles intermedia).
Pauli I; Minozzo JC; da Silva PH; Chaim OM; Veiga SS
Toxicon; 2009 May; 53(6):660-71. PubMed ID: 19673081
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous and systemic effects of varying doses of brown recluse spider venom in a rabbit model.
McGlasson DL; Harroff HH; Sutton J; Dick E; Elston DM
Clin Lab Sci; 2007; 20(2):99-105. PubMed ID: 17557708
[TBL] [Abstract][Full Text] [Related]
6. Detection of Loxosceles species venom in dermal lesions: a comparison of 4 venom recovery methods.
Krywko DM; Gomez HF
Ann Emerg Med; 2002 May; 39(5):475-80. PubMed ID: 11973554
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous loxoscelism caused by Loxosceles similis venom and neutralization capacity of its specific antivenom.
Chatzaki M; Horta CC; Almeida MO; Pereira NB; Mendes TM; Dias-Lopes C; Guimarães G; Moro L; Chávez-Olórtegui C; Horta MC; Kalapothakis E
Toxicon; 2012 Jul; 60(1):21-30. PubMed ID: 22465492
[TBL] [Abstract][Full Text] [Related]
8. Enzymatic characterization, antigenic cross-reactivity and neutralization of dermonecrotic activity of five Loxosceles spider venoms of medical importance in the Americas.
Barbaro KC; Knysak I; Martins R; Hogan C; Winkel K
Toxicon; 2005 Mar; 45(4):489-99. PubMed ID: 15733571
[TBL] [Abstract][Full Text] [Related]
9. Tetracycline and penicillin resistant Clostridium perfringens isolated from the fangs and venom glands of Loxosceles laeta: its implications in loxoscelism treatment.
Catalán A; Espoz MC; Cortés W; Sagua H; González J; Araya JE
Toxicon; 2010 Nov; 56(6):890-6. PubMed ID: 20600224
[TBL] [Abstract][Full Text] [Related]
10. Detection of Loxosceles venom in lesional hair shafts and skin: application of a specific immunoassay to identify dermonecrotic arachnidism.
Miller MJ; Gomez HF; Snider RJ; Stephens EL; Czop RM; Warren JS
Am J Emerg Med; 2000 Sep; 18(5):626-8. PubMed ID: 10999583
[TBL] [Abstract][Full Text] [Related]
11. Loxosceles spider venom induces the production of alpha and beta chemokines: implications for the pathogenesis of dermonecrotic arachnidism.
Gomez HF; Miller MJ; Desai A; Warren JS
Inflammation; 1999 Jun; 23(3):207-15. PubMed ID: 10392755
[TBL] [Abstract][Full Text] [Related]
12. Protection against dermonecrotic and lethal activities of Loxosceles intermedia spider venom by immunization with a fused recombinant protein.
Araujo SC; Castanheira P; Alvarenga LM; Mangili OC; Kalapothakis E; Chávez-Olórtegui C
Toxicon; 2003 Mar; 41(3):261-7. PubMed ID: 12565747
[TBL] [Abstract][Full Text] [Related]
13. Production of monoclonal antibodies capable of neutralizing dermonecrotic activity of Loxosceles intermedia spider venom and their use in a specific immunometric assay.
Alvarenga LM; Martins MS; Moura JF; Kalapothakis E; Oliveira JC; Mangili OC; Granier C; Chávez-Olórtegui C
Toxicon; 2003 Dec; 42(7):725-31. PubMed ID: 14757202
[TBL] [Abstract][Full Text] [Related]
14. A controlled trial of topical nitroglycerin in a New Zealand white rabbit model of brown recluse spider envenomation.
Lowry BP; Bradfield JF; Carroll RG; Brewer K; Meggs WJ
Ann Emerg Med; 2001 Feb; 37(2):161-5. PubMed ID: 11174233
[TBL] [Abstract][Full Text] [Related]
15. Molecular cloning and functional characterization of two isoforms of dermonecrotic toxin from Loxosceles intermedia (brown spider) venom gland.
da Silveira RB; Pigozzo RB; Chaim OM; Appel MH; Dreyfuss JL; Toma L; Mangili OC; Gremski W; Dietrich CP; Nader HB; Veiga SS
Biochimie; 2006 Sep; 88(9):1241-53. PubMed ID: 16581177
[TBL] [Abstract][Full Text] [Related]
16. Toxicity of two North American Loxosceles (brown recluse spiders) venoms and their neutralization by antivenoms.
de Roodt AR; Estevez-Ramírez J; Litwin S; Magaña P; Olvera A; Alagón A
Clin Toxicol (Phila); 2007 Sep; 45(6):678-87. PubMed ID: 17849243
[TBL] [Abstract][Full Text] [Related]
17. A reduced immunization scheme to obtain an experimental anti-Loxosceles laeta ("violinist spider") venom.
de Roodt AR; Litwin S; Dokmetjian JC; Vidal JC
J Nat Toxins; 2002 Aug; 11(3):193-203. PubMed ID: 12182539
[TBL] [Abstract][Full Text] [Related]
18. Neutralization of dermonecrotic and lethal activities and differences among 32-35 kDa toxins of medically important Loxosceles spider venoms in Brazil revealed by monoclonal antibodies.
Guilherme P; Fernandes I; Barbaro KC
Toxicon; 2001 Sep; 39(9):1333-42. PubMed ID: 11384721
[TBL] [Abstract][Full Text] [Related]
19. Immunological studies of Brown recluse spider venom.
Elgert KD; Ross MA; Campbell BJ; Barrett JT
Infect Immun; 1974 Dec; 10(6):1412-9. PubMed ID: 4140161
[TBL] [Abstract][Full Text] [Related]
20. A new assay for the detection of Loxosceles species (brown recluse) spider venom.
Gomez HF; Krywko DM; Stoecker WV
Ann Emerg Med; 2002 May; 39(5):469-74. PubMed ID: 11973553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
